XBI icon

SPDR S&P Biotech ETF

674 hedge funds and large institutions have $6.63B invested in SPDR S&P Biotech ETF in 2023 Q3 according to their latest regulatory filings, with 63 funds opening new positions, 182 increasing their positions, 245 reducing their positions, and 91 closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership:

less funds holding

Funds holding:

less capital invested

Capital invested by funds: $ → $

less funds holding in top 10

Funds holding in top 10:

26% less repeat investments, than reductions

Existing positions increased: 182 | Existing positions reduced: 245

27% less call options, than puts

Call options by funds: $1.32B | Put options by funds: $1.8B

31% less first-time investments, than exits

New positions opened: 63 | Existing positions closed: 91

Holders
674
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
17
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.32B
Puts
$1.8B
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
176
$2.57M
177
$2.56M
178
$2.53M
179
$2.47M
180
$2.45M
181
$2.44M
182
$2.42M
183
$2.39M
184
$2.31M
185
$2.3M
186
$2.29M
187
$2.28M
188
$2.27M
189
$2.25M
190
$2.22M
191
$2.22M
192
$2.19M
193
$2.18M
194
$2.17M
195
$2.14M
196
$2.12M
197
$2.06M
198
$2.05M
199
$2.04M
200
$1.98M